小鵬汽車(09868.HK):阿里減持因戰略調整 雙方未來仍繼續合作
對於阿里巴巴(09988.HK)(BABA.US)上周減持小鵬汽車 (09868.HK)(XPEV.US)ADS 3,300萬股,據《21世紀經濟報道》引述小鵬方面表示,阿里巴巴減持小鵬主要是其自身戰略調整,強調未來會與阿里巴巴繼續合作研發及營銷。而阿里雲仍是最重要的戰略合作夥伴之一,期待以阿里巴巴高效的人工智能基礎,令小鵬在智能電動車技術不斷創新。
小鵬還強調,去年第四季現金儲備大增,現金流進入正循環,核心經營數據向好,表示阿里巴巴減持對小鵬業務影響不大。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.